Table 5.
Hepatic expression of genes related to lipid catabolism in mice fed control or the control supplemented with trans-10, cis-12-CLA (CLA). There were no significant interactions of treatment × time. Therefore, the results are presented according to main effects (treatment and time).
| Gene | Treatment | Time | SEM | ||
|---|---|---|---|---|---|
| Control | CLA | Week 2 | Week 6 | ||
| Fatty acid oxidation and energy metabolism | |||||
| Aacs | −0.21 | −0.29 | −0.26 | −0.25 | 0.31 |
| Acox1 | −0.22a | 0.13b | −0.08 | −0.003 | 0.14 |
| Bdh1 | −0.20a | 0.13b | 0.06 | −0.12 | 0.12 |
| Cpt1a | −0.43 | −0.32 | −0.36 | −0.39 | 0.14 |
| Insig1 | −0.79 | 0.35 | −0.23 | −0.20 | 0.45 |
| Mlycd | 0.001 | −0.17 | −0.07 | −0.11 | 0.10 |
| Pdk4 | −1.85a | 0.47b | −0.81 | −0.57 | 0.50 |
| Ucp2 | −0.31a | 0.15b | −0.04 | −0.11 | 0.10 |
| Hmgcs2 | −0.16a | 0.13b | 0.10a | −0.13b | 0.11 |
| Transcription regulation | |||||
| Ppar α | −0.33 | −0.19 | −0.23 | −0.30 | 0.12 |
a,bMeans within each main effect (treatment and time) with different superscripts differ (P ≤ 0.05).
SEM: the largest standard error of the mean is shown.